Precision Life Sciences Group
3 clinical trials · Sponsor
◉ Watch Precision Life Sciences Group
| Record | Firm | Date |
|---|---|---|
| Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma (NCT02546102) | Precision Life Sciences Group | 2024-12-01 |
Track Precision Life Sciences Group automatically
Every clearance here is in the API, with alerts when new ones post.